Cova D, Cuglituri G, Rossini L, Bonfardeci G
IV Medical Department, S. Carlo Borromeo General Hospital, Milano, Italy.
Int J Clin Pharmacol Ther Toxicol. 1989 Jun;27(6):273-5.
Two different doses of a sustained-release tablet formulation of theophylline were administered to two groups of patients affected by chronic obstructive pulmonary disease. Pharmacokinetic parameters were determined after a single administration of the drug. In this experiment, the theophylline plasma levels were determined 1, 2, 4, 8, 12 and 24 h after the drug administration. In another experiment, the patients received the drug "once-daily", in the morning, for nine consecutive days. Plasma theophylline levels were monitored 24 h after the first administration and twice daily on days 3, 6 and 9. Patients receiving 700 mg/day showed theophylline levels ranging from 8.49 +/- 1.04 micrograms/ml to 20.99 +/- 2.09 micrograms/ml. In this group theophylline concentrations were found to be greater than 10 micrograms/ml also 24 h after the tablets' administration. These data show that in case of single daily theophylline administration an high dosage is necessary to maintain the drug concentration within the range of therapeutic levels.
将两种不同剂量的茶碱缓释片制剂给予两组慢性阻塞性肺疾病患者。单次给药后测定药代动力学参数。在本实验中,于给药后1、2、4、8、12和24小时测定茶碱血浆水平。在另一项实验中,患者在早晨“每日一次”连续九天接受该药物。首次给药后24小时监测血浆茶碱水平,并在第3、6和9天每日监测两次。接受700毫克/天的患者茶碱水平范围为8.49±1.04微克/毫升至20.99±2.09微克/毫升。在该组中,片剂给药后24小时也发现茶碱浓度大于10微克/毫升。这些数据表明,在每日单次给予茶碱的情况下,需要高剂量才能将药物浓度维持在治疗水平范围内。